RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions
Journal of Parkinson’s Disease · 2023
DOI: 10.3233/jpd-230070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Parkinson’s Disease, 2023. Verfasst von Daniel Pens Gelain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Oxidative Stress Studies, Department of Biochemistry, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto …. Hauptthemen laut MEDLINE: Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Oligomerization and aggregation of misfolded forms of α-synuclein are believed to be key molecular mechanisms in Parkinson’s disease (PD) and other synucleinopathies, so extensive research has attempted to understand these processes. Among diverse post-translational modifications that impact α-synuclein aggregation, glycation may take place at several lysine sites and modify α-synuclein oligomerization, toxicity, and clearance. The receptor for advanced glycation end products (RAGE) is considered a key regulator of chronic neuroinflammation through microglial activation in response to advanced glycation end products, such as carboxy-ethyl-lysine, or carboxy-methyl-lysine. The presence of RAGE in the midbrain of PD patients has been reported in the last decades and this receptor was proposed to have a role in sustaining PD neuroinflammation. However, different PD animal models demonstrated that RAGE is preferentially expressed in neurons and astrocytes, while recent evidence demonstrated that fibrillar, non-glycated α-synuclein binds to RAGE. Here, we summarize the available data on α-synuclein glycation and RAGE in the context of PD, and discuss about the questions yet to be answered that may increase our understanding of the molecular bases of PD and synucleinopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Oxidative Stress Studies, Department of Biochemistry, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Programa de Pós-Graduação em Biologia Celular e Molecular, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen, Germany.
- Max Planck Institute for Natural Sciences, Göttingen, Germany.
- Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle Upon Tyne, UK.
Zitieren
APA
Gelain, D. P., Bittencourt, R. R., Bastos Mendes, L. F., Moreira, J. C. F., & Outeiro, T. F. (2023). RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230070
Vancouver
Gelain DP, Bittencourt RR, Bastos Mendes LF, Moreira JCF, Outeiro TF. RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions. Journal of Parkinson’s Disease. 2023. doi:10.3233/jpd-230070
BibTeX
@article{Gelain2023,
author = {Gelain, Daniel Pens and Bittencourt, Reykla Ramon and Bastos Mendes, Luiz Filipe and Moreira, José Claudio Fonseca and Outeiro, Tiago Fleming},
title = {RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions},
journal = {Journal of Parkinson’s Disease},
year = {2023},
doi = {10.3233/jpd-230070}
}
EUVIMED